


Telara Pharma Revenue
Biotechnology Research • L'Hospitalet de Llobregat, Catalonia, Spain • 1-10 Employees
Telara Pharma revenue & valuation
| Annual revenue | $513,330 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,700,000 |
| Total funding | No funding |
Key Contact at Telara Pharma
Teresa Tarragó
Ceo At Telara Pharma
Company overview
| Headquarters | L'Hospitalet de Llobregat, Catalonia, Spain |
| Phone number | +3419572020 |
| Website | |
| NAICS | 541714 |
| Founded | 2020 |
| Employees | 1-10 |
| Socials |
Telara Pharma Email Formats
Telara Pharma uses 1 email format. The most common is {first name}.{last name} (e.g., john.doe@telarapharma.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@telarapharma.com | 100% |
About Telara Pharma
Telara Pharma is a global leader in repurposing the drug cilastatin to make new therapies for severe inflammatory disorders like Acute Kidney Injury (AKI) and Glaucoma. The scientific team of TELARA has spent years studying toxic and non-toxic aggressions suffered by the kidneys with the aim of preventing and treating AKI. The company arises out of the pioneering work on nephroprotection carried out with cilastatin by the team of the KOL Dr. Alberto Tejedor. We are currently advancing cilastatin into phase II clinical trials for the treatment of AKI induced by toxics, sepsis, and sepsis-included acute kidney failure and moving forward proprietary programs to clinical trials to repurpose cilastatin for neuroinflammatory disorders like Glaucoma and other ophthalmologic indications.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Telara Pharma has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Telara Pharma has never raised funding before.
Frequently asked questions
4.8
40,000 users



